{{Rsnum
|rsid=7869487
|Chromosome=9
|position=114818634
|Orientation=plus
|GMAF=0.2585
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 10.8 | 41.5 | 47.7
| HCB | 17.8 | 35.6 | 46.7
| JPT | 17.8 | 33.3 | 48.9
| YRI | 0.0 | 6.5 | 93.5
| ASW | 0.0 | 0.0 | 0.0
| CHB | 17.8 | 35.6 | 46.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{omim
|desc=INFLAMMATORY BOWEL DISEASE 16; IBD16
|id=612259
|rsnum=7869487
}}

{{PMID|17663424|OA=1
}} TNFSF15 is an ethnic-specific IBD gene.

{{PMID|19174806}} TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort.

{{PMID|19262684|OA=1
}} IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein.

{{PMID Auto
|PMID=24269700
|Title=Genetic risk and protective factors of TNFSF15 gene variants detected using single nucleotide polymorphisms in Hungarians with psoriasis and psoriatic arthritis
}}

{{PMID Auto
|PMID=25028192
|Title=Associations between TNFSF15 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: A meta-analysis
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}